Gentler hormone may replace hCG in IVF procedures

06/18/2013 | New Scientist

A team of researchers is testing the hypothesis that a hormone called kisspeptin could replace the human chorionic gonadotropin hormone used in in vitro fertilization procedures. Kisspeptin is believed to be a gentler hormone that does not run the same risks as the potent hCG hormone, which can cause ovarian hyperstimulation syndrome. The team tested kisspeptin in 30 women undergoing the IVF procedure and the first healthy baby was born in April. Final results will be known in six months, said team leader Waljit Dhillo.

View Full Article in:

New Scientist

Published in Brief:

SmartBrief Job Listings for Education

Job Title Company Location
Senior ELL Technical Assistance and Curriculum Specialist (8270)
American Institute for Researcher
Chicago, IL
Senior Researcher (8194)
American Institute for Researcher
Washington, DC
Technical Assistance Associate (8330)
American Institute for Researcher
Chicago, IL
Technical Assistance Consultant (8336)
Chicago, IL
Director of Professional Services
Engaging Schools, Inc.
Cambridge, MA